# Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Gladiator HA Coated Modular Femoral Stems

> **NCT02314611** · — · TERMINATED · sponsor: **MicroPort Orthopedics Inc.** · enrollment: 154 (actual)

## Conditions studied

- Joint Disease

## Interventions

- **DEVICE:** PROFEMUR® Gladiator HA Coated Modular Femoral Stem

## Key facts

- **NCT ID:** NCT02314611
- **Lead sponsor:** MicroPort Orthopedics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12
- **Primary completion:** 2019-11
- **Final completion:** 2023-11
- **Target enrollment:** 154 (ACTUAL)
- **Why stopped:** The primary reason for this study was to collect safety and performance data to meet regulatory requirements. However, these requirements have changed over time. Our recentassessment has determined that now there is sufficient data on this product.
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02314611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02314611, "Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Gladiator HA Coated Modular Femoral Stems". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02314611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*